Cure My Disease

Don't miss your cure!

 Log in / Sign up

Back connective tissue under scrutiny in fibromyalgia

NCT ID NCT07839065

Knowledge-focused Sponsor: Diskapi Teaching and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers compare the thickness of the thoracolumbar fascia, a sheet of connective tissue in the lower back, between women with fibromyalgia and healthy women. They use ultrasound to measure the fascia at two points in the spine on both sides of the body. The study also checks whether fascia thickness relates to pain intensity, widespread pain, and symptom severity in the fibromyalgia group. The goal is to understand whether fascia changes are part of fibromyalgia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study finds a link between fascia thickness and fibromyalgia symptoms, it could guide future research into fascia-focused treatments or better ways to assess the condition.
What could go wrong
This is a small observational study of 60 women, so it cannot prove cause and effect. Ultrasound measurements can vary between operators, and any link found may not hold in larger or more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of women aged 18-65 years. The fibromyalgia group will include women diagnosed with fibromyalgia according to the 2016 revised American College of Rheumatology criteria. The healthy control group will consist of women without fibromyalgia or chronic widespread pain. Healthy controls will be selected to be as comparable as possible to the fibromyalgia group in terms of age and body mass index. All participants will be recruited at Ankara Etlik City Hospital, Algology Clinic.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female sex * Age between 18 and 65 years * For the fibromyalgia group, diagnosis of fibromyalgia according to the 2016 revised American College of Rheumatology criteria * For the healthy control group, absence of fibromyalgia or chronic widespread pain * Willingness to participate and provision of written informed consent Exclusion Criteria: * Pregnancy * Previous lumbar surgery or severe spinal deformity * Active infection, malignancy, or systemic inflammatory disease * History of trauma or surgery, or presence of a skin lesion at the ultrasonographic measurement site * Inability to complete the study assessments or provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    RECRUITING

    Ankara, Ankara, 06500, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.